COBALT REHABILITATION FARGO — History
CCN 353026 | 3-year financial timeline | COVID resilience: 86/100
🛡️ Public data only — no PHI permitted on this instance.
$27M
Latest Revenue (FY2022)
+194.7%
Revenue CAGR (3yr)
19.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $3M | $21M | $27M | +27.1% | +194.7% |
| Operating Expenses | $7M | $18M | $22M | +18.1% | +81.9% |
| Operating Margin | -100.0% | 12.8% | 19.0% | +48.9% | +0.0% |
| Net Income | $-3M | $3M | $5M | +89.3% | +0.0% |
| Licensed Beds | 40 | 42 | 42 | +0.0% | +2.5% |
| Total Patient Days | 1,960 | 12,040 | 14,613 | +21.4% | +173.0% |
| Medicare Day % | 59% | 77% | 80% | +4.1% | +16.6% |
| Medicaid Day % | nan% | nan% | 1% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 86/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +768.4% ($3M → $27M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▲ Growing
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+194.7%
This Hospital
+7.6%
State Avg
Latest Margin
19.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $38M | 78.5% |
| FY2024 (proj) | $50M | 138.0% |
| FY2025 (proj) | $62M | 197.5% |